Lotus Pharmaceuticals Stock Performance
| LTUS Stock | USD 0 0.0002 5.41% |
Lotus Pharmaceuticals holds a performance score of 5 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.45, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Lotus Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Lotus Pharmaceuticals is expected to outperform it. Use Lotus Pharmaceuticals total risk alpha, downside variance, as well as the relationship between the Downside Variance and day median price , to analyze future returns on Lotus Pharmaceuticals.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Lotus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Lotus |
Lotus Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.34 in Lotus Pharmaceuticals on November 6, 2025 and sell it today you would earn a total of 0.01 from holding Lotus Pharmaceuticals or generate 2.94% return on investment over 90 days. Lotus Pharmaceuticals is currently generating 1.0862% in daily expected returns and assumes 15.7316% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Lotus, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lotus Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Lotus Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 66.88 |
Based on a normal probability distribution, the odds of Lotus Pharmaceuticals to move above the current price in 90 days from now is about 66.88 (This Lotus Pharmaceuticals probability density function shows the probability of Lotus Pink Sheet to fall within a particular range of prices over 90 days) .
Lotus Pharmaceuticals Price Density |
| Price |
Predictive Modules for Lotus Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lotus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lotus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lotus Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lotus Pharmaceuticals is not an exception. The market had few large corrections towards the Lotus Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lotus Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lotus Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.16 | |
β | Beta against Dow Jones | -1.45 | |
σ | Overall volatility | 0.0007 | |
Ir | Information ratio | 0.06 |
Lotus Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lotus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lotus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lotus Pharmaceuticals is way too risky over 90 days horizon | |
| Lotus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lotus Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Lotus Pharmaceuticals currently holds 5.24 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Lotus Pharmaceuticals has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Lotus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Lotus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lotus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lotus to invest in growth at high rates of return. When we think about Lotus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. |
Lotus Pharmaceuticals Fundamentals Growth
Lotus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lotus Pharmaceuticals, and Lotus Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lotus Pink Sheet performance.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 762.17 K | |||
| Shares Outstanding | 27.82 M | |||
| Price To Earning | 0.18 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 72.7 M | |||
| EBITDA | 10.31 M | |||
| Cash And Equivalents | 158.91 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.24 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 3.58 X | |||
| Cash Flow From Operations | 26.78 M | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 103.18 M | |||
| Retained Earnings | 65 M | |||
| Current Asset | 8 M | |||
| Current Liabilities | 14 M | |||
About Lotus Pharmaceuticals Performance
Assessing Lotus Pharmaceuticals' fundamental ratios provides investors with valuable insights into Lotus Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Lotus Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.Things to note about Lotus Pharmaceuticals performance evaluation
Checking the ongoing alerts about Lotus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lotus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lotus Pharmaceuticals is way too risky over 90 days horizon | |
| Lotus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lotus Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Lotus Pharmaceuticals currently holds 5.24 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Lotus Pharmaceuticals has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Lotus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Lotus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lotus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lotus to invest in growth at high rates of return. When we think about Lotus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. |
- Analyzing Lotus Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lotus Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Lotus Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lotus Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lotus Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lotus Pharmaceuticals' pink sheet. These opinions can provide insight into Lotus Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.